Israel’s Secret Nuclear Biological and Chemical Weapons (NBC)
Global Research, March 02, 2015
ilmanifesto.it (original in Italian)
Region: Middle East & North Africa
Theme: Militarization and WMD
1201
445 40
3988
This article was first published by Global Research in October 2013.
For
years, Syria and Egypt refused to abandon their chemical weapons facing
a threatening neighbor, Israel, which develops very sophisticated ones,
in addition to biological and nuclear weapons. However, while Syria has
joined the Organization for the Prohibition of Chemical Weapons , we
are taking a look at Israeli activities.
The
UN inspectors who monitor chemical weapons in Syria would have much to
do if they were sent to monitor the nuclear, biological and chemical
weapons (NBC) of Israel.
But
according to the rules of “international law”, they cannot do so.
Israel has not signed the Nuclear Non-Proliferation Treaty, nor the
Convention Banning Biological Weapons , and has signed but not ratified
the Convention Banning Chemical Weapons.
The
entrance of the Israel Institute for Biological Research, Ness- Ziona .
This structure is the cover for the research and manufacturing of
Israeli chemical and biological weapons.
According
to Jane’s Defense Weekly, Israel – the only nuclear power in the Middle
East, has 100 to 300 nuclear warheads and their appropriate vectors (
ballistic and cruise missiles and fighter-bombers ). According to SIPRI
estimates, Israel has produced 690-950 kg of plutonium, and continues to
produce as much as necessary to make from 10 to 15 bombs of the
Nagasaki type each year.
It
also produces tritium, a radioactive gas with which neutron warheads
are made, which cause minor radioactive contamination but higher
lethality. According to various international reports, also quoted by
the Israeli newspaper Ha’aretz, biological and chemical weapons are
developed at the Institute for Biological Research, located in Ness-
Ziona, near Tel Aviv. Officially, 160 scientists and 170 technicians are
part of the staff, who for five decades have performed research in
biology, chemistry, biochemistry, biotechnology, pharmacology, physics
and other scientific disciplines. The Institute, along with the Dimona
nuclear center , is “one of the most secretive institutions in Israel”
under direct jurisdiction of the Prime Minister. The greatest secrecy
surrounds research on biological weapons, bacteria and viruses that
spread among the enemy and can trigger epidemics. Among them, the
bacteria of the bubonic plague (the ” Black Death ” of the Middle Ages )
and the Ebola virus, contagious and lethal, for which no therapy is
available.
With
biotechnology, one can produce new types of pathogens which the target
population is not able to resist, not having the specific vaccine. There
is also strong evidence of research to develop biological weapons that
can destroy the human immune system. Officially the Israeli Institute
conducts research on vaccines against bacteria and viruses, such as
anthrax funded by the Pentagon, but it is obvious that they can develop
new pathogens for war use.
The
same expedient is used in the United States and in other countries to
get around the conventions prohibiting biological and chemical weapons.
In Israel the screed secret was partially torn by the inquiry that was
conducted, with the help of scientists, by the Dutch journalist Karel
Knip. It has also come out that toxic substances developed by the
Institute have been used by the Mossad to assassinate Palestinian
leaders. Medical evidence indicates that in Gaza and Lebanon, Israeli
forces used weapons of a new design: they leave the body intact outside
but, upon penetration, dévitalise tissues, carbonise liver and bones,
and coagulate the blood. This is possible with nanotechnology, the
science that casts microscopic structures by building them atom by atom.
Italy
also participates in the development of these weapons, linked to Israel
by a military cooperation agreement and being its number one European
partner in research and development. In the last Finance Act, Italy
provided an annual allocation of € 3 million for projects of Italian-
Israeli joint research. Like the one indicated in the last notice of the
Farnesina (Italian Ministry of Foreign Affairs), “new approaches to
combat pathogens resistant to treatment.”
In this way, the Israel Institute for Biological Research could render pathogens even more resistant.
Translation Roger Lagassé
No comments:
Post a Comment